Results 31 to 40 of about 562,468 (202)

VPAgs-Dataset4ML: A Dataset to Predict Viral Protective Antigens for Machine Learning-Based Reverse Vaccinology

open access: yesData, 2023
Reverse vaccinology (RV) is a computer-aided approach for vaccine development that identifies a subset of pathogen proteins as protective antigens (PAgs) or potential vaccine candidates. Machine learning (ML)-based RV is promising, but requires a dataset
Zakia Salod, Ozayr Mahomed
doaj   +1 more source

Reverse Vaccinology in Plasmodium falciparum 3D7 [PDF]

open access: yesJournal of Immunological Techniques in Infectious Diseases, 2016
A timely immunization can be effective against certain diseases and can save thousands of lives. However, for some diseases it has been difficult, so far, to develop an efficient vaccine. Malaria, a tropical disease caused by a parasite of the genus Plasmodium, is one example. Bioinformatics has opened the way to new lines of experimental investigation
Isea, Raul   +2 more
openaire   +2 more sources

Advanced vaccinology education: Landscaping its growth and global footprint

open access: yes, 2020
International audienceIn preparation for the first Global Vaccinology Training workshop in 2018, a survey of 27 advanced vaccinology courses was conducted to provide a landscape of the vaccinology education around the world.
Lambert, Paul-Henri   +5 more
core   +1 more source

Pathogen proteins eliciting antibodies do not share epitopes with host proteins: a bioinformatics approach. [PDF]

open access: yesPLoS ONE, 2007
The best way to prevent diseases caused by pathogens is by the use of vaccines. The advent of genomics enables genome-wide searches of new vaccine candidates, called reverse vaccinology.
Isaac Amela, Juan Cedano, Enrique Querol
doaj   +1 more source

Non-muscle Myosin II: Role in Microbial Infection and Its Potential as a Therapeutic Target

open access: yesFrontiers in Microbiology, 2019
Currently, the major measures of preventing and controlling microbial infection are vaccinations and drugs. However, the appearance of drug resistance microbial mounts is main obstacle in current anti-microbial therapy.
Lei Tan   +5 more
doaj   +1 more source

PanRV: Pangenome-reverse vaccinology approach for identifications of potential vaccine candidates in microbial pangenome

open access: yesBMC Bioinformatics, 2019
Background A revolutionary diversion from classical vaccinology to reverse vaccinology approach has been observed in the last decade. The ever-increasing genomic and proteomic data has greatly facilitated the vaccine designing and development process ...
Kanwal Naz   +6 more
doaj   +1 more source

Protocol for a scoping review of potential vaccine candidates predicted by VaxiJen for different viral pathogens between 2017–2021

open access: yesSystematic Reviews, 2022
Background Vaccination is essential for the prevention of infectious diseases and has helped to reduce disease-related mortality, such as pneumonia. However, traditional vaccine development is time-consuming and risky.
Zakia Salod, Ozayr Mahomed
doaj   +1 more source

Relationship of Noncoding RNA and Swine Viruses

open access: yesIntervirology, 2022
Background: Swine viruses are well known as a threat to the pig industry. Many signaling pathways and a number of proteins were discovered to participate in the immune responses to swine viruses.
Manxin Fang, Wei Hu, Zhibang Deng
doaj   +1 more source

Post-Genomics and Vaccine Improvement for Leishmania

open access: yesFrontiers in Microbiology, 2016
Leishmaniasis is a parasitic disease that primarily affects Asia, Africa, South America and the Mediterranean basin. Despite extensive efforts to develop an effective prophylactic vaccine, no promising vaccine is available yet.
Negar eSeyed   +2 more
doaj   +1 more source

Fight fire with fire: the need for a vaccine based on intrinsic disorder and structural flexibility

open access: yesExploration of Immunology, 2022
The absence of advancement in finding efficient vaccines for several human viruses, such as hepatitis C virus (HCV), human immunodeficiency virus type 1 (HIV-1), and herpes simplex viruses (HSVs) despite 30, 40, and even 60 years of research ...
Vladimir N. Uversky
doaj   +1 more source

Home - About - Disclaimer - Privacy